DeepMed Research

CHILDREN'S HOSPITAL OF PHILADELPHIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1855-01-01

Employees: -

Market Cap: -

Website: http://www.chop.edu/

Clinical Trials

Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Intervention Subjects

First Posted Date: 2005-06-10

Last Posted Date: 2014-03-04

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 439

Registration Number: NCT00113633

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia

Phase 3

Terminated

Conditions: Leukemia

Interventions: Drug: cyclophosphamide
Drug: etoposide
Drug: cyclosporine
Procedure: allogeneic bone marrow transplantation
Radiation: Total Body Irradiation
Drug: methotrexate
Radiation: Radiation
Drug: Busulfan
Drug: Mesna

First Posted Date: 2004-05-19

Last Posted Date: 2013-10-16

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 43

Registration Number: NCT00002961

Locations: 🇺🇸
Cardinal Glennon Children's Hospital, Saint Louis, Missouri, United States
🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States
🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States

and more 15 locations

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Phase 1

Terminated

Conditions: Leukemia
Lymphoma

Interventions: Drug: sirolimus

First Posted Date: 2003-09-11

Last Posted Date: 2015-03-12

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 10

Registration Number: NCT00068302

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

Not Applicable

Terminated

Conditions: Neurofibromatosis Type 1
Precancerous Condition

Interventions: Radiation: fludeoxyglucose F 18
Radiation: gadopentetate dimeglumine

First Posted Date: 2003-05-07

Last Posted Date: 2014-04-04

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 18

Registration Number: NCT00060008

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Phase 2

Completed

Conditions: Neurofibromatosis Type 1
Precancerous Condition

Interventions: Drug: Methotrexate
Drug: Vinblastine

First Posted Date: 2003-01-27

Last Posted Date: 2018-08-08

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 23

Registration Number: NCT00030264

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Phase 2

Terminated

Conditions: Brain Tumors
Central Nervous System Tumors
Medulloblastoma

Interventions: Drug: Cisplatin
Drug: Cyclophosphamide
Drug: Etoposide
Drug: Lomustine
Drug: Vincristine
Radiation: Craniospinal Radiation

First Posted Date: 2003-01-27

Last Posted Date: 2019-04-25

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 30

Registration Number: NCT00031590

Locations: 🇺🇸
Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States
🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Phase 1

Terminated

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-01-27

Last Posted Date: 2015-03-19

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 11

Registration Number: NCT00031577

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Winship Cancer Institute of Emory University, Egleston, Georgia, United States

Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)

Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Sodium 4-Phenylbutyrate (4PBA)
Drug: Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)
Drug: Placebo

First Posted Date: 2001-06-04

Last Posted Date: 2009-01-09

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 12

Registration Number: NCT00016744

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Not Applicable

Completed

Conditions: Hyperinsulinism

First Posted Date: 2000-02-25

Last Posted Date: 2015-03-25

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 8

Registration Number: NCT00004699

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Phase 2

Completed

Conditions: Hyperinsulinism

First Posted Date: 2000-02-25

Last Posted Date: 2015-03-25

Lead Sponsor: Children's Hospital of Philadelphia

Target Recruit Count: 16

Registration Number: NCT00004700

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy